Author

P. Kothai Sundaram

Observed name: Poongothai Sundaram

Observed institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Yale University, Columbus Community Clinical Oncology Program, The Ohio State University

OpenAlex ID: A5091797293

Sorafenib in Platinum-Treated Patients with Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group (SWOG 0435) Phase II Trial

2010 · Barbara J. Gitlitz, James Moon, et al. · Journal of Thoracic Oncology · 60

Phase I Study of the Sequential Combination of Interleukin-12 and Interferon Alfa-2b in Advanced Cancer: Evidence for Modulation of Interferon Signaling Pathways by Interleukin-12

2005 · Charles F. Eisenbeis, Gregory B. Lesinski, et al. · Journal of Clinical Oncology · 29

A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)

2024 · Jessica Mezzanotte-Sharpe, Anne ONeill, et al. · Breast Cancer Research and Treatment · 4

Works count: 3

Citation count: 92

H-index: 3

I10-index: 2